CELU logo
CELU NASDAQ US

Celularity Inc. - Class A Common Stock

Healthcare · Biotechnology Website · IPO May 2019
$1.33
▲ +$0.02 (+1.53%)
Vol 13K
4
Quality Score
fail
Mkt Cap
$31.6M
ROE
-272.4%
Margin
-198.8%
D/E
478.53
Beta
0.80
52W
$1–$4

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

RLYB
Rallybio Corp
$29.0M
ALGS
Aligos Therapeutics Inc
$57.4M
ATRA
Atara Biotherapeutics Inc
P/E 5.6
$130.4M
LITS
Lite Strategy Inc
$48.6M
SNSE
Sensei Biotherapeutics Inc
$13.5M
CRVO
CervoMed Inc
$73.1M
NXTC
NextCure Inc
$49.7M
RNXT
RenovoRx Inc
$30.8M

Earnings

Beat rate: 25.0%
Next Report May 07, 2026
EPS Estimate: $-1.53
Quarter EPS Est EPS Act Surprise
Dec 2025 $-1.53 — —
Sep 2025 $-1.53 $-0.88 +$0.65
Jun 2025 $-0.77 $-1.02 $-0.26
Mar 2025 $-0.77 $-0.84 $-0.08

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -272.6% -272.6% -272.6% -272.4% -272.4%
P/E (TTM) — — — — — —
Net Margin -427.6% -106.8% -165.2% -165.2% -165.0% -198.8%
Gross Margin 8.6% 72.4% 55.1% 55.1% 55.1% 50.6%
D/E Ratio — 478.53 478.53 478.53 478.53 478.53
Current Ratio 0.25 0.38 0.25 0.25 0.25 0.16

Key Ratios

ROA (TTM)
-65.0%
P/S (TTM)
0.78
P/B
5.2
EPS (TTM)
$-3.33
CF/Share
$-0.44
Rev Growth 3Y
+36.5%
52W High
$4.35
52W Low
$1.00
$1.00 52-Week Range $4.35

How does CELU compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CELU AAPG ABEO ABOS ABP

CELU valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0.8
▼ 94% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
5.2
▲ 111% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CELU profitability vs Biotechnology peers

ROE
-272.4%
▼ 305% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-198.8%
▲ 31% above peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
50.6%
▼ 36% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-65.0%
▼ 39% below peers (-46.7%)
vs Peers
vs Industry
Weak

CELU financial health vs Biotechnology peers

D/E ratio
478.5
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
0.2
▼ 96% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.8
▼ 17% below peers (1.0)
vs Peers
vs Industry
More volatile

CELU fundamentals radar

CELU Peer median Industry

CELU profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CELU vs peers: key metrics

Latest News

No related news yet